PRA
ProAssurance Corporation24.17
-0.09-0.37%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
1.24BP/E (TTM)
37.18Basic EPS (TTM)
0.65Dividend Yield
0%Recent Filings
8-K
Strong Q4 earnings, merger update
ProAssurance posted Q4 net income of $33.4M ($0.64/share) and full-year $50.9M ($0.99/share), with operating income hitting $42.4M ($0.82/share) quarterly and $83.9M ($1.62/share) yearly. Non-GAAP combined ratio sharpened to 104.2% for 2025 from 109.0%, fueled by $53.1M favorable medical liability reserve development. Doctors Company merger advances, targeting June 30, 2026 close despite pending California, Pennsylvania approvals. Regulatory hurdles persist.
10-K
FY2025 results
ProAssurance's FY2025 net premiums written fell 4% y/y to $0.9B, with gross premiums down 3% to $1.0B amid retention pressure and non-renewals, yet Q4 momentum showed pricing gains of 8-9% in MPL offsetting volume dips. Net premiums earned dropped 3.5% to $934M, but $90M favorable prior-year reserve development—versus $40M in 2024—drove the calendar-year net loss ratio to 71.2% from 76.4%, with current accident year steady at ~81%. Investment income climbed 8% to $156M on higher yields; operating ratio improved to 89.8%. Debt steady at $422M; $56M buyback capacity remains. Pending Doctors Company merger risks regulatory delays.
8-K
Execs get early incentives
ProAssurance authorized ~80% of expected 2025 cash incentives to named executives on December 5, 2025, to sidestep 280G parachute penalties tied to its pending merger with The Doctors Company, announced March 19. Payments total $2.5M across CEO Edward Rand ($998K) and others. Merger risks loom large.
8-K
Q3 profits dip, merger progresses
ProAssurance posted Q3 net income of $1.4M ($0.03/share), yet operating income hit $7.9M ($0.15/share) amid non-operating drags. Net premiums written fell 6.5% to $261.3M, with Specialty P&C renewal rates up 8% but retention at 84%. Non-GAAP combined ratio slipped to 112.2%. Doctors merger advances, eyed for June 2026 close despite pending reviews.
10-Q
Q3 FY2025 results
ProAssurance's Q3 net premiums earned fell 4.0% y/y to $233.4M while net income dropped to $1.4M ($0.03/share) from $16.4M ($0.32/share), reflecting less favorable prior-year reserve releases. Yet investment income climbed 8.5% y/y to $40.4M on higher yields. Losses rose to 79.8% of premiums, up 7.3 pts y/y, but reserves fell $139M q/q to $3.1B. Debt holds steady at $422.8M; cash $54.5M. Merger with The Doctors Company awaits California, Pennsylvania, Texas approvals. Regulatory delays threaten timely close.
IPO
Website
Employees
Sector
Industry
ALL
Allstate Corporation (The)
209.51-2.43
BOW
Bowhead Specialty Holdings Inc.
27.71-0.36
CNA
CNA Financial Corporation
47.13-0.16
KNSL
Kinsale Capital Group, Inc.
385.16-7.01
MKL
Markel Group Inc.
2140.70-19.52
PGR
Progressive Corporation (The)
231.81-4.55
PLMR
Palomar Holdings, Inc.
127.54+2.02
RLI
RLI Corp.
65.42+0.40
RNR
RenaissanceRe Holdings Ltd.
272.44+0.90
WRB
W.R. Berkley Corporation
68.56-0.54